SYNCRIP and cancer: Studies have shown that HABP4 overexpression resulted in reduced cancer cell proliferation, mainly because of a G1 phase arrest [15], and that HABP4 could influence the splicing pattern of the E1A pre-mRNA by binding with the endogenous splicing proteins hnRNPQ and SFRS9 [30].